Editorial Policy

How the guides on MyDeprescriber are researched, written, sourced and corrected — and what we will not do.

Who writes this

Clinical content on MyDeprescriber is published under the byline of Lindsay Hill, DNP, PMHNP-BC, a board-certified psychiatric mental health nurse practitioner. Author credentials appear on every guide.

Where the information comes from

We write from primary and guideline-level sources, not from other people’s blog posts. In practice that means peer-reviewed literature, national clinical guidelines, regulator-approved prescribing information, and specialist reference works. The sources we lean on most often are:

Peer-reviewed research indexed in PubMed, with a preference for systematic reviews and guidelines over single studies
National guidance — NICE, the Royal College of Psychiatrists, SAMHSA, the American Geriatrics Society Beers Criteria
FDA-approved prescribing information for the specific medication
The Maudsley Deprescribing Guidelines (Horowitz & Taylor, Wiley, 2024), and the Ashton Manual for benzodiazepines

Every guide carries a visible reference list with links, so any claim can be traced to its source.

Our standards

We represent mainstream medical consensus, and where our emphasis differs from a common clinical practice — as with taper speed — we show the guideline and the evidence that supports the position rather than simply asserting it.
We name genuine uncertainty. Parts of the deprescribing evidence base are actively debated. Where a question is open, we say it is open.
We do not promise outcomes. We make no claim about how any individual will respond to a taper, how quickly, or with what result. Any guarantee we offer relates only to our educational products, never to a clinical outcome.
We do not diagnose or prescribe. Nothing here is individual medical advice or a substitute for a prescriber who knows your history.
We use plain language, and we write for two audiences separately — patients and clinicians — rather than blurring them.

Use of AI in production

We use AI tools to help draft and research, in the same way many publishers now do. No guide is published on the basis of AI output alone: sources are checked against the primary literature, and every article is published under a named clinician’s byline, who is accountable for it. We do not publish AI-generated clinical claims that we have not verified against a cited source.

Corrections

If we get something wrong, we want to fix it. Email hello@mydeprescriber.com with the page and the issue. Substantive corrections to clinical content are made promptly and the page’s updated date is changed to reflect the revision. We do not change a page’s date unless the content has genuinely been revised.

Commercial disclosure

MyDeprescriber earns revenue from clinician certification and from premium directory listings. Premium placement affects a Provider’s position and presentation in directory results and is disclosed as such. It is never presented as a clinical recommendation from us, and it has no bearing on the content of our guides. Certification is earned by examination and cannot be purchased.

We accept no pharmaceutical industry funding and run no third-party display advertising.

Independence of editorial from commercial

Our guides do not recommend individual Providers, and no Provider can pay to be named or favourably described in editorial content.